Key facts
- This page summarizes Funicular Funds, LP's Form 3 filing for ARCA biopharma, Inc. (ORKA).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Jul 2022, 19:12.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
This Form 3 is filed by Funicular Funds, LP (the "Reporting Person" or the "Fund"). The Reporting Person, the Funicular Fund ("Funicular"), Cable Car Capital LLC ("Cable Car") and Jacob Ma- Weaver may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person, Funicular and Cable Car and Mr. Ma-Weaver disclaim beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Footnote F2
Represents securities directly owned by the Fund. On July 1, 2022, subsequent to their initial purchase, the Common Stock and Put Options held by Funicular were transferred internally from Funicular to the Fund. Funicular, as a feeder fund to the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Cable Car, as the general partner of the Fund, may be deemed to beneficially own the securities directly owned by the Fund. Mr. Ma-Weaver, as the Managing Member of Cable Car, may be deemed to beneficially own the securities directly owned by the Fund.